{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:17:30Z","timestamp":1793827050476,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8135","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,10,8]]},"DOI":"10.1038\/s41586-026-10957-y","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:01:41Z","timestamp":1785769301000},"page":"508-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gasdermin D-mediated delivery of caspase inhibitors to suppress pyroptosis"],"prefix":"10.1038","volume":"658","author":[{"given":"Katarzyna M.","family":"Groborz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-1521","authenticated-orcid":false,"given":"Melissa E.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Wickliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bauernfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-8070","authenticated-orcid":false,"given":"Robert S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Plise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2605-1398","authenticated-orcid":false,"given":"Ponien","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3415-2710","authenticated-orcid":false,"given":"Wyne P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Budayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8518-2328","authenticated-orcid":false,"given":"Julia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Kalinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Drag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-1740","authenticated-orcid":false,"given":"Nobuhiko","family":"Kayagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4197-0340","authenticated-orcid":false,"given":"Kim","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-6252","authenticated-orcid":false,"given":"Marcin","family":"Poreba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-0326","authenticated-orcid":false,"given":"Vishva M.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"10957_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton, K., Strasser, A., Kayagaki, N. & Dixit, V. M. Cell death. Cell 187, 235\u2013256 (2024).","journal-title":"Cell"},{"key":"10957_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04240-3","volume":"12","author":"S Dhani","year":"2021","unstructured":"Dhani, S., Zhao, Y. & Zhivotovsky, B. A long way to go: caspase inhibitors in clinical use. Cell Death Dis. 12, 949 (2021).","journal-title":"Cell Death Dis."},{"key":"10957_CR3","doi-asserted-by":"publisher","first-page":"a008680","DOI":"10.1101\/cshperspect.a008680","volume":"5","author":"M Poreba","year":"2013","unstructured":"Poreba, M., Str\u00f3zyk, A., Salvesen, G. S. & Drag, M. Caspase substrates and inhibitors. Cold Spring Harb. Perspect. Biol. 5, a008680 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10957_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52110-1","volume":"15","author":"LDJ Schiffelers","year":"2024","unstructured":"Schiffelers, L. D. J. et al. Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application. Nat. Commun. 15, 8266 (2024).","journal-title":"Nat. Commun."},{"key":"10957_CR5","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/nprot.2017.091","volume":"12","author":"M Poreba","year":"2017","unstructured":"Poreba, M., Salvesen, G. S. & Drag, M. Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity. Nat. Protoc. 12, 2189\u20132214 (2017).","journal-title":"Nat. Protoc."},{"key":"10957_CR6","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1074\/jbc.RA117.001329","volume":"293","author":"MLG Ramirez","year":"2018","unstructured":"Ramirez, M. L. G. et al. Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1. J. Biol. Chem. 293, 7058\u20137067 (2018).","journal-title":"J. Biol. Chem."},{"key":"10957_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00726-013-1654-2","volume":"46","author":"M Poreba","year":"2014","unstructured":"Poreba, M. et al. Unnatural amino acids increase activity and specificity of synthetic substrates for human and malarial cathepsin C. Amino Acids 46, 931\u2013943 (2014).","journal-title":"Amino Acids"},{"key":"10957_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"10957_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"514","author":"J Shi","year":"2014","unstructured":"Shi, J. et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514, 187\u2013192 (2014).","journal-title":"Nature"},{"key":"10957_CR10","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1021\/bi00179a020","volume":"33","author":"NA Thornberry","year":"1994","unstructured":"Thornberry, N. A. et al. Inactivation of Interleukin-1.beta. converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry 33, 3934\u20133940 (1994).","journal-title":"Biochemistry"},{"key":"10957_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/sj.cr.7310112","volume":"16","author":"AB Berger","year":"2006","unstructured":"Berger, A. B., Sexton, K. B. & Bogyo, M. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res. 16, 961\u2013963 (2006).","journal-title":"Cell Res."},{"key":"10957_CR12","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1021\/acs.molpharmaceut.8b00688","volume":"15","author":"EC Chen","year":"2018","unstructured":"Chen, E. C. et al. Evaluating the utility of canine Mdr1 knockout Madin-Darby canine kidney i cells in permeability screening and efflux substrate determination. Mol. Pharm. 15, 5103\u20135113 (2018).","journal-title":"Mol. Pharm."},{"key":"10957_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013255 (2015).","journal-title":"Nat. Med."},{"key":"10957_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll, R. C. et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat. Chem. Biol. 15, 556\u2013559 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"10957_CR15","doi-asserted-by":"publisher","first-page":"e3000354","DOI":"10.1371\/journal.pbio.3000354","volume":"17","author":"LV Walle","year":"2019","unstructured":"Walle, L. V. et al. MCC950\/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. PLoS Biol. 17, e3000354 (2019).","journal-title":"PLoS Biol."},{"key":"10957_CR16","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1021\/jm050307e","volume":"48","author":"SD Linton","year":"2005","unstructured":"Linton, S. D. et al. First-in-class pan caspase inhibitor developed for the treatment of liver disease. J. Med. Chem. 48, 6779\u20136782 (2005).","journal-title":"J. Med. Chem."},{"key":"10957_CR17","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.1240248","volume":"341","author":"N Kayagaki","year":"2013","unstructured":"Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246\u20131249 (2013).","journal-title":"Science"},{"key":"10957_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1126\/science.1240988","volume":"341","author":"JA Hagar","year":"2013","unstructured":"Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K. & Miao, E. A. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341, 1250\u20131253 (2013).","journal-title":"Science"},{"key":"10957_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"MC Wei","year":"2001","unstructured":"Wei, M. C. et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727\u2013730 (2001).","journal-title":"Science"},{"key":"10957_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213\u2013218 (2004).","journal-title":"Nature"},{"key":"10957_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","volume":"440","author":"S Mariathasan","year":"2006","unstructured":"Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228\u2013232 (2006).","journal-title":"Nature"},{"key":"10957_CR22","doi-asserted-by":"publisher","first-page":"18864","DOI":"10.1074\/jbc.RA118.004350","volume":"293","author":"FL Zhong","year":"2018","unstructured":"Zhong, F. L. et al. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding. J. Biol. Chem. 293, 18864\u201318878 (2018).","journal-title":"J. Biol. Chem."},{"key":"10957_CR23","doi-asserted-by":"publisher","first-page":"107959","DOI":"10.1016\/j.celrep.2020.107959","volume":"32","author":"NM de Vasconcelos","year":"2020","unstructured":"de Vasconcelos, N. M. et al. An apoptotic caspase network safeguards cell death induction in pyroptotic macrophages. Cell Rep. 32, 107959 (2020).","journal-title":"Cell Rep."},{"key":"10957_CR24","doi-asserted-by":"publisher","first-page":"e202000735","DOI":"10.26508\/lsa.202000735","volume":"3","author":"R Heilig","year":"2020","unstructured":"Heilig, R. et al. Caspase-1 cleaves Bid to release mitochondrial SMAC and drive secondary necrosis in the absence of GSDMD. Life Sci. Alliance 3, e202000735 (2020).","journal-title":"Life Sci. Alliance"},{"key":"10957_CR25","doi-asserted-by":"publisher","first-page":"e2350515","DOI":"10.1002\/eji.202350515","volume":"54","author":"SJ Thygesen","year":"2024","unstructured":"Thygesen, S. J. et al. Fluorochrome-labeled inhibitors of caspase-1 require membrane permeabilization to efficiently access caspase-1 in macrophages. Eur. J. Immunol. 54, e2350515 (2024).","journal-title":"Eur. J. Immunol."},{"key":"10957_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.aar7607","volume":"362","author":"S R\u00fchl","year":"2018","unstructured":"R\u00fchl, S. et al. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science 362, 956\u2013960 (2018).","journal-title":"Science"},{"key":"10957_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.abl3855","volume":"376","author":"AT Ritter","year":"2022","unstructured":"Ritter, A. T. et al. ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack. Science 376, 377\u2013382 (2022).","journal-title":"Science"},{"key":"10957_CR28","doi-asserted-by":"publisher","first-page":"19140","DOI":"10.1073\/pnas.0603788103","volume":"103","author":"A Zamborlini","year":"2006","unstructured":"Zamborlini, A. et al. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc. Natl Acad. Sci. USA 103, 19140\u201319145 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10957_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"10957_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","volume":"593","author":"S Xia","year":"2021","unstructured":"Xia, S. et al. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature 593, 607\u2013611 (2021).","journal-title":"Nature"},{"key":"10957_CR31","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1097\/CCM.0000000000006028","volume":"51","author":"AR Moore","year":"2023","unstructured":"Moore, A. R. et al. Elevated plasma interleukin-18 identifies high-risk acute respiratory distress syndrome patients not distinguished by prior latent class analyses using traditional inflammatory cytokines: a retrospective analysis of two randomized clinical trials. Crit. Care Med. 51, e269\u2013e274 (2023).","journal-title":"Crit. Care Med."},{"key":"10957_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04025-w","volume":"26","author":"AJ Boyle","year":"2022","unstructured":"Boyle, A. J. et al. Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial. Crit. Care 26, 164 (2022).","journal-title":"Crit. Care"},{"key":"10957_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/CCM.0000000000003816","volume":"47","author":"AJ Rogers","year":"2019","unstructured":"Rogers, A. J. et al. Association of elevated plasma interleukin-18 level with increased mortality in a clinical trial of statin treatment for acute respiratory distress syndrome. Crit. Care Med. 47, 1089\u20131096 (2019).","journal-title":"Crit. Care Med."},{"key":"10957_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41418-018-0110-y","volume":"26","author":"M Poreba","year":"2019","unstructured":"Poreba, M. et al. Caspase selective reagents for diagnosing apoptotic mechanisms. Cell Death Differ. 26, 229\u2013244 (2019).","journal-title":"Cell Death Differ."},{"key":"10957_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.chembiol.2016.05.020","volume":"23","author":"M Poreba","year":"2016","unstructured":"Poreba, M. et al. Counter selection substrate library strategy for developing specific protease substrates and probes. Cell Chem. Biol. 23, 1023\u20131035 (2016).","journal-title":"Cell Chem. Biol."},{"key":"10957_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/meth.1999.0745","volume":"17","author":"HR Stennicke","year":"1999","unstructured":"Stennicke, H. R. & Salvesen, G. S. Caspases: preparation and characterization. Methods 17, 313\u2013319 (1999).","journal-title":"Methods"},{"key":"10957_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41592-022-01507-1","volume":"19","author":"D Ershov","year":"2022","unstructured":"Ershov, D. et al. TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines. Nat. Methods 19, 829\u2013832 (2022).","journal-title":"Nat. Methods"},{"key":"10957_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"10957_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R. et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics 22, 433 (2021).","journal-title":"BMC Bioinformatics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10957-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10957-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10957-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:07:46Z","timestamp":1791371266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10957-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":39,"journal-issue":{"issue":"8135","published-print":{"date-parts":[[2026,10,8]]}},"alternative-id":["10957"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10957-y","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.M.G., M.E.T., I.S., K.E.W., B.L., S.B., R.S.J., E.P., E.S.L., P.K., W.P.L., J.Z., H.B., C.M.R., N.K., K.N. and V.M.D. were employees of Genentech.\u00a0The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}